Repro Med Systems Stock Probability of Future Stock Price Finishing Over 2.08
| KRMD Stock | USD 2.08 0.02 0.97% |
Closest to current price Repro long CALL Option Payoff at Expiration
Repro |
Repro Med Target Price Odds to finish over 2.08
The tendency of Repro Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.08 | 90 days | 2.08 | about 76.65 |
Based on a normal probability distribution, the odds of Repro Med to move above the current price in 90 days from now is about 76.65 (This Repro Med Systems probability density function shows the probability of Repro Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.61 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Repro Med will likely underperform. Additionally Repro Med Systems has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Repro Med Price Density |
| Price |
Predictive Modules for Repro Med
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Repro Med Systems. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Repro Med's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Repro Med Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Repro Med is not an exception. The market had few large corrections towards the Repro Med's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Repro Med Systems, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Repro Med within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.1 | |
β | Beta against NYSE Composite | 1.61 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.02 |
Repro Med Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Repro Med for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Repro Med Systems can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Repro Med Systems had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 28.52 M. Net Loss for the year was (13.74 M) with profit before overhead, payroll, taxes, and interest of 15.37 M. | |
| Repro Med Systems currently holds about 18.27 M in cash with (4.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Roughly 58.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 |
Repro Med Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Repro Stock often depends not only on the future outlook of the current and potential Repro Med's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Repro Med's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 45.6 M | |
| Cash And Short Term Investments | 11.5 M |
Repro Med Technical Analysis
Repro Med's future price can be derived by breaking down and analyzing its technical indicators over time. Repro Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Repro Med Systems. In general, you should focus on analyzing Repro Stock price patterns and their correlations with different microeconomic environments and drivers.
Repro Med Predictive Forecast Models
Repro Med's time-series forecasting models is one of many Repro Med's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Repro Med's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Repro Med Systems
Checking the ongoing alerts about Repro Med for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Repro Med Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Repro Med Systems had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 28.52 M. Net Loss for the year was (13.74 M) with profit before overhead, payroll, taxes, and interest of 15.37 M. | |
| Repro Med Systems currently holds about 18.27 M in cash with (4.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Roughly 58.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 |
Check out Repro Med Backtesting, Repro Med Valuation, Repro Med Correlation, Repro Med Hype Analysis, Repro Med Volatility, Repro Med History as well as Repro Med Performance. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Repro Stock analysis
When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Repro Med's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (0.30) | Revenue Per Share 0.625 | Quarterly Revenue Growth (0.02) | Return On Assets (0.18) |
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.